RxDoctor Payments Data

John Varlotto, MD

Radiation Oncology · Huntington, WVNPI 1366489148

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $81,455 of the $119,776 with a category attached, or 68.0%. AstraZeneca accounts for 76.8% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $41,256, 6.9 times the $6,011 reported in 2019. Among radiation oncology clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$119,776in general payments, 2019–2025

Across 135 payments — averaging $887.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$92K
  • Medtronic$17K
  • Novocure Inc.$2K
  • Elekta, Inc.$2K
  • Astrazeneca UK Limited$2K
  • Covidien LP$2K
  • plus $4K from 16 others
$67,346in research payments, 2019–2025

Across 2 payments — averaging $33,673 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$66K
  • Covidien LP$925

What the payments were for

  • Consulting fees$24,16820%
  • Speaking & faculty fees$81,45568%
  • Travel & lodging$9,4788%
  • Food & beverage$4,6664%
  • Education$90%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$119,776 in reported general payments places this provider in the 95th percentile of 29 radiation oncology providers in West Virginia.

See all radiation oncology providers in West Virginia

Medicare billing

Part B allowed, 2024
$152,331
Medicare patients
126
Services billed
1,402

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl39$592
Pentoxifylline23$422
Memantine Hcl12$366
Dexamethasone13$149
Olanzapine11$112
Omeprazole13$73

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Huntington

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →